Treating COPD Comorbidities: A Market Opportunity for Systemic Anti-Inflammatory Agents? - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Electronic

Treating COPD Comorbidities: A Market Opportunity for Systemic Anti-Inflammatory Agents?
Decision Resources, Inc., March 2008, Pages: 42



		Description



		Table of Contents



		Companies Mentioned



		Enquire before Buying


	Send to a Friend

Send to a Friend

To email a friend details of Treating COPD Comorbidities: A Market Opportunity for Systemic Anti-Inflammatory Agents? complete the form below and click on "Send".

* Required Information

Your Friend's Details

Friend's Full Name *

Friend's Email Address *

A message for your Friend

Your Contact Details

Your Name *

Email Address *

Customers who bought this item also bought

Asthma & COPD Therapeutics

Pipeline Insight: Asthma/COPD - Targeted Therapies on the Horizon

COPD - Another Reason to Quit

Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis

COPD Drug Discovery: How New Generation Therapies Seek to Target Underlying Disease

Asthma and COPD Drug Discoveries: What the Future Holds

Chronic Obstructive Pulmonary Disease (Copd) Update - Considerable Unmet Needs Invigorate Interest in the Copd Market

Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential

Commercial Insight: Asthma & COPD - On the verge of generic entry

Commercial Insight: Asthma and Copd - Combinations breathe life into the asthma and Copd markets

U.S. COPD Market: Therapeutic Overview and Patient Outlook

U.S. COPD Market - Therapeutic Overview and Patient Outlook

Top of page